Isoquinoline, 5,7-dichloro-1,2,3,4-tetrahydro-2-(triphenylmethyl)- |
2-三苯甲基-5,7-二氯-1,2,3,4-四氢异喹啉 |
1289646-72-5 |
3-AMINO-3-(4-FLUOROPHENYL)PROPANENITRILE |
3-氨基-3-(4-氟苯基)丙腈 |
1270488-91-9 |
(R)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoic acid |
(R)-2-氨基-3-(3-(甲基磺酰基)苯基)丙酸 |
1270132-45-0 |
6,7-Quinolinediol, 4-chloro- |
6,7-Quinolinediol, 4-chloro- |
1256637-72-5 |
(Z)-1-acetyl-3-(methoxy-phenyl-methylene)-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid methyl ester |
1253769-13-9 |
1253769-13-9 |
(Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylic acid compound with 3-benzoyl-2-oxoindoline-6-carboxylic acid |
尼达尼布杂质17 |
1253768-91-0 |
Cabozantinib Impurity 46 |
Cabozantinib Impurity 46 |
1247859-37-5 |
Febuxostat impurity 37 |
非布索坦杂质37 |
1229019-33-3 |
Clopidogrel IMpurity 3 |
氯吡格雷杂质3 |
1198220-10-8 |
2(1H)-Isoquinolinecarboxylic acid, 5,7-dichloro-3,4-dihydro-6-[[[(1S)-1-[[3-(methylsulfonyl)phenyl]methyl]-2-oxo-2-(phenylmethoxy)ethyl]amino]carbonyl]-, 1,1-dimethylethyl ester |
立他斯特杂质 |
1194550-61-2 |
Cabozantinib Impurity 14 |
卡博替尼杂质14 |
1175127-32-8 |
Nintedanib impurity YZ |
尼达尼布杂质49 |
1139455-52-9 |
Trityl olMesartan MedoxoMil iMpurity II |
奥美沙坦酯杂质 |
1040405-56-8 |
Desethyl Carbodenafil |
去乙基卡地那非 |
1027192-92-2 |
Fluticasone Impurity 5 |
Fluticasone Impurity 5 |
192191-51-8 |
Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)- |
6,7-二甲氧基喹啉-4-(4-硝基苯基)喹啉 |
190728-24-6 |
[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-17-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-11-yl] propanoate |
[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-17-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-11-yl] propanoate |
181527-42-4 |
4,5''-Di(desmethyl) Omeprazole Sulfide |
奥美拉唑杂质15 |
176219-12-8 |
N-Desmethyl-N-cyclopentyl Tadalafil |
N-Desmethyl-N-cyclopentyl Tadalafil |
171596-32-0 |
Methylprednisolone Impurity 4 |
琥珀酸甲泼尼龙4 |
167997-11-7 |